000 05053cam a2200421Ii 4500
001 95890
003 ES-MaUEC
005 20230102112727.0
006 m o d
007 cr cnu|||unuuu
008 170427s2017 nyua ob 001 0 eng d
020 _a1493966979
_q(electronic bk.)
020 _a9781493966974
_q(electronic bk.)
020 _z1493966952
020 _z9781493966950
_q(print)
040 _aN$T
_cN$T
_dGW5XE
_dEBLCP
_dYDX
_dUAB
_dN$T
_dESU
_dOCLCF
_dVT2
_dCOO
_dOTZ
_dOCL
_dIOG
_dU3W
_dES-MaUEC
_bspa
050 4 _aRG493
_b2017 EB
100 1 _aTan, Puay Hoon,
_eautor
245 1 0 _aAtlas of differential diagnosis in breast pathology
_cPuay Hoon Tan, Aysegul A. Sahin.
264 1 _aNew York
_bSpringer International Publishing
_c2017
300 _a1 recurso en línea (xx, 625 páginas)
_bilustraciones (algunas a color)
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
490 0 _aAtlas of anatomic pathology
504 _aIncluye referencias bibliográficas e índice
505 0 _aSeries Preface; Preface; Acknowledgments; Contents; 1: Normal Breast and Physiological Changes; Physiological Changes; Menstrual Cyclic Changes; Pregnancy- and Lactation-Related Changes; Menopause-Related Changes; Calcifications; Non-calcified Crystalloids; References; 2: Developmental, Reactive, and Inflammatory Conditions; Ectopic Breast Tissue; Definition; Clinical and Epidemiological Features; Imaging Features; Pathologic Features; Macroscopic Pathology; Microscopic Pathology; Differential Diagnosis; Normal Skin Adnexa; Lipoma; Fibroepithelial Polyp
505 8 _aDiabetic Mastopathy (Sclerosing Lymphocytic Lobulitis) Definition; Clinical and Epidemiological Features; Imaging Features; Pathologic Features; Macroscopic Pathology; Microscopic Pathology; Differential Diagnosis; Fibrous Scar; Fibromatosis; Amyloid; IgG4-Related Sclerosing Mastitis; Malignant Lymphoma; Prognosis and Therapy Considerations; Infections; Definition; Clinical and Epidemiological Features; Imaging Features; Pathologic Features; Macroscopic Pathology; Microscopic Pathology; Differential Diagnosis; Necrotising Granulomatous Vasculitis
505 8 _aGranulomatous Lobular Mastitis Prognosis and Therapy Considerations; References; 3: Fibroepithelial Lesions; Fibroadenoma; Definition; Clinical and Epidemiological Features; Imaging Features; Pathologic Features; Macroscopic Pathology; Microscopic Pathology; Differential Diagnosis; Prognosis and Therapy Considerations; Phyllodes Tumour; Definition; Clinical and Epidemiological Features; Imaging Features; Pathologic Features; Macroscopic Pathology; Microscopic Pathology; Differential Diagnosis
505 8 _aLymph Node Metastasis Prognosis and Therapy Considerations; Duct Ectasia; Definition; Clinical and Epidemiological Features; Imaging Features; Pathologic Features; Macroscopic Pathology; Microscopic Pathology; Differential Diagnosis; Xanthogranulomatous Mastitis; Fat Necrosis; Rosai-Dorfman Disease (RDD); Pagetoid Spread of Lobular Neoplasia; Granular Cell Tumour; Histiocytoid Invasive Lobular Carcinoma; Invasive Apocrine Carcinoma; Prognosis and Therapy Considerations; Fat Necrosis; Definition; Clinical and Epidemiological Features; Imaging Features; Pathologic Features
505 8 _aMacroscopic Pathology Microscopic Pathology; Differential Diagnosis; Invasive Breast Carcinoma; Metaplastic Carcinoma; Prognosis and Therapy Considerations; Mastitis; Definition; Clinical and Epidemiological Features; Imaging Features; Pathologic Features; Macroscopic Pathology; Microscopic Pathology; Differential Diagnosis; Periductal Mastitis with Granulomas; Infective Granulomatous Inflammation; Necrotising Granulomatous Vasculitis; Sarcoidosis; Carcinoma-Related Granulomas; Silicone Granuloma; Prognosis and Therapy Considerations
520 3 _aThis atlas illustrates the range of breast lesions and their differential diagnoses, with pictorial correlation of gross and microscopic features. Where relevant, radiological images are incorporated. A description of normal, developmental and physiological breast morphology will serves as introduction to the main content of this atlas. Classification of tumors is based on the latest World Health Organisation Classification of Tumors of the Breast, 4th edition, 2012. As immunohistochemistry is a key adjunctive platform in the workup of breast lesions as well as used in prognostic evaluation of breast cancers, appropriate examples are interspersed. Molecular tools used in corroborating diagnoses and a discussion of therapy related changes are included. .
650 7 _aMamas
_xEnfermedades
_2embne
_0(OCoLC)fst00838317
_0
_9173368
700 1 _aSahin, Aysegul A.,
_eautor
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-1-4939-6697-4
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988 _aSpringer_Medicine_2017
998 _b02/2018
_dz
_e-
_zSI
999 _c95890
_d95890
_x1